Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
375.25
+8.56 (2.33%)
Jan 8, 2026, 3:05 PM EST - Market open
Elevance Health Analyst Ratings
Total Analysts
18
Consensus Rating
Buy
Price Target
$392.06
Upside
+4.48%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wolfe Research | Wolfe Research | Hold → Buy Upgrades $425 | Hold → Buy | Upgrades | $425 | +13.26% | Jan 8, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $403 → $424 | Buy | Maintains | $403 → $424 | +12.99% | Jan 7, 2026 |
| Barclays | Barclays | Buy Maintains $385 → $404 | Buy | Maintains | $385 → $404 | +7.66% | Jan 5, 2026 |
| Deutsche Bank | Deutsche Bank | Strong Buy → Hold Downgrades $332 → $320 | Strong Buy → Hold | Downgrades | $332 → $320 | -14.72% | Dec 19, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $359 → $352 | Hold | Maintains | $359 → $352 | -6.20% | Dec 18, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $380 → $400 | Strong Buy | Maintains | $380 → $400 | +6.60% | Nov 26, 2025 |
| Mizuho | Mizuho | Buy Maintains $420 → $400 | Buy | Maintains | $420 → $400 | +6.60% | Nov 4, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $384 → $394 | Buy | Maintains | $384 → $394 | +5.00% | Oct 28, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $330 → $380 | Strong Buy | Maintains | $330 → $380 | +1.27% | Oct 23, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $412 → $403 | Buy | Maintains | $412 → $403 | +7.40% | Oct 22, 2025 |
| Barclays | Barclays | Buy Maintains $395 → $385 | Buy | Maintains | $395 → $385 | +2.60% | Oct 22, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $316 → $359 | Hold | Maintains | $316 → $359 | -4.33% | Oct 14, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $343 | Hold | Initiates | $343 | -8.59% | Oct 14, 2025 |
| B of A Securities | B of A Securities | Hold Maintains $330 → $370 | Hold | Maintains | $330 → $370 | -1.40% | Oct 10, 2025 |
| Mizuho | Mizuho | Buy Maintains $342 → $420 | Buy | Maintains | $342 → $420 | +11.93% | Oct 9, 2025 |
| Barclays | Barclays | Buy Maintains $373 → $395 | Buy | Maintains | $373 → $395 | +5.26% | Oct 9, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.